Johnson & Johnson announced the departure of a top senior executive, in today's bite-sized hospital and health industry news from California, Colorado, and New Jersey.

• California: Keck Medical Center of USC on Thursday announced that Marty Sargeant, who has served as interim CEO since July 2020, will take over as permanent CEO, effective immediately. According to Rod Hanners, CEO of Keck Medicine of USC, "In his time as interim, Marty has acquired new talent, aligned our medical teams to advance patient care and enhanced surgical procedures—all during a pandemic." Hanners added, "His commitment to putting patients first and creating a work environment where health care providers can thrive make him an ideal leader for Keck Medicine." (Jensik, Becker's Hospital Review, 10/7)

• Colorado: Centura Health announced that Jeremy Pittman will take over as CEO of its Castle Rock Adventist Hospital, effective Oct. 24. Over the past 15 years, Pittman has held several leadership roles at Centura, most recently serving as CFO at Porter Adventist Hospital in Denver. Before he joined Porter Adventist, Pittman served as CFO and COO of Castle Rock Adventist and held leadership positions in finance and surgical services at Littleton Adventist Hospital. (Jensik, Becker's Hospital Review, 10/11)

• New Jersey: Johnson & Johnson on Tuesday announced the departure of Paul Stoffels, a top scientist who oversaw the development of a Covid-19 vaccine. Stoffels will retire as vice chairman of the executive committee and chief scientific officer, effective Dec. 31. According to Stoffels, "As a physician and a scientist, it is gratifying to see the health care landscape transformed as we unlock the best science and technology to deliver innovative medicines to solve the world's toughest health challenges." (Loftus, Wall Street Journal, 10/12)